Announced details
Treatment of patients with locally advanced or locally recurrent head and neck cancer
A response was observed in 8 of 10 evaluable cases 90 days after treatment (Complete Response or Partial Response).
Patient treatments began in March 2026. The initial treatment experience from 10 evaluable cases was reported at 90 days after treatment.
Efforts are under way to promote the BNCT business in China. Capital, personnel and specific business relationships are Not disclosed.
Listed as the operator responsible for developing and operating the Hainan BNCT Center in Bo'ao, Hainan Province, China. Other details, including its location, representative, business activities, capital and year of establishment, are Not disclosed.
Bo'ao, Hainan Province, China
In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.
22nd Annual Meeting of the Japanese Society of Neutron Capture Therapy (held on 1 August 2026 at Kyoto University)
| Item | Details |
|---|---|
| Names of Products / Services Covered | BNCT treatment using an accelerator-based BNCT system |
| Counterparty | 鵬博（海南）硼中子医療科技有限公司 (Pengbo) |
| Counterparty overview | Listed as the operator responsible for developing and operating the Hainan BNCT Center in Bo'ao, Hainan Province, China. Other details, including its location, representative, business activities, capital and year of establishment, are Not disclosed. |
| Relationship with the Company | Efforts are under way to promote the BNCT business in China. Capital, personnel and specific business relationships are Not disclosed. |
| Launch date | March 2026 (patient treatments began at the Hainan BNCT Center; actual results) |
| Applicable area | Treatment of patients with locally advanced or locally recurrent head and neck cancer |
| Location | Bo'ao, Hainan Province, China |
| Quantitative Effects | A response was observed in 8 of 10 evaluable cases 90 days after treatment (Complete Response or Partial Response). |
| Usage history | Patient treatments began in March 2026. The initial treatment experience from 10 evaluable cases was reported at 90 days after treatment. |
| Source | 22nd Annual Meeting of the Japanese Society of Neutron Capture Therapy (held on 1 August 2026 at Kyoto University) |
Items this document does not state (8)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Progress in establishing a BNCT treatment framework and accumulating clinical experience in China led to clinical application in actual medical practice and the academic presentation of the results.